Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic Relevance of GATA 3 Expression in Urinary Bladder Carcinoma of Divergent Differentiation and Other Histological Variants

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

GATA binding protein 3, a zinc finger transcription factor, has now been demonstrated as a valuable and sensitive marker for conventional urothelial carcinoma with sparse literature related to its expression in various histological variants. It is a prospective study where 74 consecutive cases of bladder carcinoma were included between August 2016 and January 2017 followed by immunohistochemistry to assess GATA 3 expression in conventional as well as different urothelial carcinoma (UC) variants. Overall, 57 of the 74 lesions (77%) demonstrated nuclear staining for GATA 3. GATA 3 expression significantly correlated with histological grade (P < 0.001) and muscle invasion (P = 0.005). Divergent differentiation was observed in 54% (40/74) of the total cases. The study included 12 different variants of urothelial carcinoma. All or majority of the cases of clear cell (6/6, 100%), glandular (6/8, 75%), and sarcomatoid (4/6, 66.7%) variants expressed GATA 3 in a moderate to strong fashion and belonged to group III or IV. Nested variant, small cell carcinoma, pure squamous cell carcinoma, and squamous component of urothelial carcinoma with squamous differentiation do not show any GATA 3 expression. GATA 3 was expressed more intensely as well as in greater number of tumor cells at lymph node metastatic tumor deposits as compared to the primary tumor. GATA 3 expression was not significantly associated with tumor stage or patients’ clinical outcomes. GATA 3 is expressed in majority of variants of UC albeit with variable staining; however, situation is challenging in some variants known to be associated with poor prognosis like nested variant, small cell carcinoma, and squamous cell carcinoma where it is not expressed. Hence, the sensitivity of this determinant is diminished in these variants, which may affect the interpretation of GATA 3 stains at metastatic sites as well as their distinction from secondary bladder involvement, by tumors of non-urothelial origin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Data may be made available on request.

References

  1. Shanks JH, Iczkowski KA (2009) Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology 54(7):885–900

    Article  CAS  Google Scholar 

  2. Higgins JPT, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX et al (2007) Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 31(5):673–680

    Article  Google Scholar 

  3. Liang Y, Heitzman J, Kamat AM, Dinney CP, Czerniak B, Guo CC (2014) Differential expression of GATA-3 in urothelial carcinoma variants. Hum Pathol 45(7):1466–1472

    Article  CAS  Google Scholar 

  4. Verduin L, Mentrikoski MJ, Heitz CT, Wick MR (2016) The utility of GATA3 in the diagnosis of urothelial carcinomas with variant morphologic patterns. Appl Immunohistochem Mol Morphol 24(7):509–513

    Article  CAS  Google Scholar 

  5. International Agency for Research on Cancer (2016) WHO classification of tumours of the urinary system and male genital organs (IARC WHO classification of tumours) 4. WHO/IARC Press, Lyon

  6. Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R et al (2012) Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 36(10):1472–1476

    Article  Google Scholar 

  7. Mohammed KH, Siddiqui MT, Cohen C (2016) GATA3 immunohistochemical expression in invasive urothelial carcinoma. Urol Oncol 34(10):432.e9-432.e13

    Article  CAS  Google Scholar 

  8. Hoang LL, Tacha D, Bremer RE, Haas TS, Cheng L (2015) Uroplakin II (UPII), GATA3, and p40 are highly sensitive markers for the differential diagnosis of invasive urothelial carcinoma. Appl Immunohistochem Mol Morphol AIMM 23(10):711–716

    Article  CAS  Google Scholar 

  9. Agarwal H, Babu S, Rana C, Kumar M, Singhai A, Shankhwar SN et al (2019) Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma. Indian J Pathol Microbiol 62(2):244–250

    Article  Google Scholar 

  10. Matsushita K, Cha EK, Matsumoto K, Baba S, Chromecki TF, Fajkovic H et al (2011) Immunohistochemical biomarkers for bladder cancer prognosis. Int J Urol Off J Jpn Urol Assoc 18(9):616–629

    CAS  Google Scholar 

  11. McKenney JK, Amin MB (2005) The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms. Semin Diagn Pathol 22(1):69–87

    Article  Google Scholar 

  12. Pons F, Orsola A, Morote J, Bellmunt J (2011) Variant forms of bladder cancer: basic considerations on treatment approaches. Curr Oncol Rep 13(3):216–221

    Article  Google Scholar 

  13. Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE et al (2014) Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol 45(7):1473–1482

    Article  CAS  Google Scholar 

  14. López-Beltrán A, Martín J, García J, Toro M (1988) Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen. Histol Histopathol. 3(1):63–8

    PubMed  Google Scholar 

  15. Rao Q, Williamson SR, Lopez-Beltran A, Montironi R, Huang W, Eble JN, et al (2013) Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol Off J U S Can Acad Pathol Inc 26(5):725–32.

  16. Ellis CL, Chang AG, Cimino-Mathews A, Argani P, Youssef RF, Kapur P et al (2013) GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder. Am J Surg Pathol 37(11):1756–1760

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India

    Chanchal Rana, Suresh Babu, Harshita Agarwal, Atin Singhai & Madhu Kumar

  2. Department of Urology, King George’s Medical University, Lucknow, Uttar Pradesh, India

    Vishwajeet Singh, R. J. Sinha & S. N. Shankhwar

Authors
  1. Chanchal Rana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suresh Babu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harshita Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atin Singhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Madhu Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vishwajeet Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. J. Sinha
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. N. Shankhwar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have appropriate contribution to the manuscript as stated in the table as follows. Contribution details (to be ticked marked as applicable):

 

1

2

3

4

5

6

7

8

Concepts

Y

 

Y

     

Design

Y

 

Y

     

Definition of intellectual content

Y

Y

Y

     

Literature search

Y

 

Y

     

Clinical studies

    

Y

Y

Y

Y

Experimental studies

Y

Y

Y

     

Data acquisition

Y

 

Y

     

Data analysis

Y

Y

Y

     

Statistical analysis

Y

 

Y

     

Manuscript preparation

Y

Y

Y

Y

Y

Y

Y

Y

Manuscript editing

Y

Y

Y

Y

Y

Y

Y

Y

Manuscript review

Y

Y

Y

Y

Y

Y

Y

Y

Guarantor

Y

Y

Y

Y

Y

Y

Y

Y

Corresponding author

Correspondence to Suresh Babu.

Ethics declarations

Code availability

Not applicable

Ethics Approval

Approved by Institutional ethical committee.

Consent to Participate

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rana, C., Babu, S., Agarwal, H. et al. Diagnostic Relevance of GATA 3 Expression in Urinary Bladder Carcinoma of Divergent Differentiation and Other Histological Variants. Indian J Surg Oncol 12, 678–685 (2021). https://doi.org/10.1007/s13193-021-01394-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-021-01394-6

Keywords

Search

Navigation